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AN INTELLIGENT DECISION SUPPORT TOOL FOR EARLY
DIAGNOSIS OF FUNCTIONAL PITUITARY ADENOMAS
I. Z. GOKBAY1 , S. KARAMAN2 , S. YARMAN3 , B. S. YARMAN4 §
Abstract. In this work, a web based integrated Medical Decision Support System
(MDSS) tool for mainly early diagnosis of functional pituitary adenomas (i.e., soma-
totrophinoma, corticotrophinoma and prolactinoma) is developed. In the MDSS tool,
hormone diseases are described by means of well-classified set of attributes generated
from the typical sign and symptoms of disorders.The proposed tool is based on a sta-
tionary linear stochastic system model which specifically predicts the selected hormone
diseases employing certain system parameters. The MDSS tool is user friendly which
includes questions and answers at the opening session of the self-test. Questions and
answers session will be completed by “yes” or “no” type of simple-responses. Based on
our clinical results, MDSS tool yields more than 99% correct decisions on the selected
hormone diseases. It is expected that effective use of the proposed MDSS tool will save
substantial amount of valuable time of an expert endocrinologists and minimizes the
cost of diagnosis. Furthermore, it will provide the opportunity for early diagnosis for the
patient and the expert medical doctor to take the necessary preventive measures.
Keywords: Acromegaly, Cushing’s Disease, Endocrinology, Medical Decision Support
System, MDSS Tool, Pituitary Adenomas, Prolactinoma.
AMS Subject Classification: 83-02, 99A00
1. Introduction
The exponential growth of the internet usage lies behind the advent of the personal
computers [1]. Using computers and mobile technologies at work, at home, at school
individuals can connect and find novel ways of accessing information, organizing memory,
creating global communities and social networking. Web-based databases allow us to
access information in new ways, often with remarkable ease. That is why internet has
become a new domain of human activity. As a result of all these it is also a new domain
for those who study human [2].
In 1984, a lecture given by Peter Reichertz was about the past, present and future of
hospital systems [3]. In the meanwhile, there has been an enormous progress in medicine
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as well as informatics. Thirty years later from Peter Reichertz’s lecture, there have been
tremendous developments done in health information systems. With the increase of data in
health care setting there has been a shift from paper-based to computer-based processing
and storage. Also the shift from institution-centered hospital information systems towards
regional and global health information systems (HIS), beside health care professionals and
administrator patients and health consumers are included to health information systems
as a user. Nowadays, HIS data are also used for health care planning as well as clinical
and epidemiological research and medical decision support tools.
Medical decision support system (MDSS) tools aims to provide with valid, applicable,
and useful information may result in care decisions that are more concordant with current
recommendations based on some pre-coded domain knowledge [4] for family physicians,
internists to guide the patients, Medical Emergency Services [5]-[7] and with the web-based
self-test designs also for the patients [8]-[14]. With web-based questionnaires, medical
lecture notes or medical groups, which periodically send medical information and reports,
allow patients to be less dependent on clinicians for information [15]. Web-based MDSS
tools can support this growing involvement of patients in clinical decision-making through
interactive tools that allow patients to explore relevant information [16]-[17].
With relevant, high quality, and accessible web-based information tools people became
more aware about the diseases which were not previously well-known such as pituitary
adenomas. Moreover, it is very easy to face a surplus of medical information. On the
other hand, symptoms of the pituitary disease can be confused with the different diseases.
For this reason acquired information from internet may induce physiological distressed
and finally they can reduce their life quality. Consequently, people may admit to different
physicians that are related or unrelated to their complaints. So that when they admit to a
non-specialist about their disease, symptoms can progress and become more complicated.
Besides that, this will result loss of time and money.
On the basis of this knowledge, in this paper a reliable Medical Decision Support Sys-
tem (MDSS) that will be useful for the patients, for family physicians and internists to
guide the patients to the endocrinology clinics for evaluation of pituitary adenoma namely,
acromegaly, Cushing’s disease and prolactinoma will be developed. If the patient coin-
cides with a complete MDSS self-test tool, they may end up with a proper early diagnosis
and directed to a specialist. The designed tool will also prevent malpractice for general
physician and save time and reduce the cost [18].
The MDSS-tool is developed with basic decision making (or equivalently stochastic-
mathematical) models and web programming techniques for some Endocrinology diseases
based on the general classified information.
In the present research work, we verified that computer aided guidance can be provided
with patients in the field of Endocrinology. The proposed MDSS tool is developed on
three major excess hormone secreting diseases of Pituitary Gland; namely Acromegaly,
Cushing’s disease and Prolactinoma.
The proposed tool for early diagnosis consists of eight major blocks as listed below.




5. Links and Contact,
6. Information pages about Endocrinology (4 pages),
7. Three major diseases of pituitary gland; namely Acromegaly, Cushing’s disease and
Prolactinoma,
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8. Admin module.
The main page is to guide the patients properly to determine their health state.
The second block includes the relevant news about the patients regarding the develop-
ments in pituitary-gland disease.
The third block is dedicated to patients to share their opinions and views regarding
their symptoms.
The fourth block is assigned to the patients to make an early diagnosis about their
health status if they have Acromegaly, Cushing’s disease, Prolactinoma or none of them.
This module is the essential S/W package to assess the major pituitary-gland diseases by
means of a multi-dimensional stochastic model. The model is linear as explained in the
following section.
The fifth module provides the patients with the relevant name of the medical-experts
and institutions in the field.
The sixth module reveals the basic information about the Endocrine Systems of the
human body.
The seventh block briefs the user about major hormone diseases such as Acromegaly,
Cushing’s disease and Prolactinoma.
The last block is for the administrators to add, change or remove information from the
database wherever they are.
The complete computer package was prepared with software engineering concepts, con-
cerned with all aspects of software production from the early stages of system specification
through to maintaining the system after its life cycle.
During the software production and uploading, the following developments gadgets (or
instruments) were employed.
• Apache server (for local hosting),
• PHP (for scripting),
• MySQL (for the database),
• Macromedia Dreamviewer MX,
• PHPEd,
• Homesite (as editors),
• CuteFTP (to upload files),
• MySQL-Front (to manage the database from the cyberspace).
Let us shortly introduce some of the major tools above.
Apache is a Unix-based, open-source web server that is used to host most sites on the
Internet. The first version of Apache was developed by a group of programmers in 1995
[19]. Originally, it was a UNIX product, but now versions for Windows, OS/2 and other
operating system platforms exist As with most open-source projects, there are numerous
add-ons and tailored versions of the server available, which are created using the Apache
module API. The name comes from its origins as “a patchy” web server. The name comes
from its origins as a series of “patch files”. As a result of its sophisticated features, excellent
performance, and low price (it’s free), Apache has become the world’s most popular web
server.
PHP (Personal Home Pages) is an open-source, Pre-Hypertext Preprocessor, server-
side, cross-platform scripting language for creating dynamic Web pages ??. A dynamic
Web page is a page that interacts with the user, so that each user visiting the page sees
customized information. The PHP commands embedded in HTML and processed on a
web-server before sending the page to the client browser. Because PHP is embedded within
tags, the author can jump between HTML and PHP instead of having to rely on heavy
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amounts of code to output HTML. An HTML page with PHP script is typically given a
file name suffix of “.php”, “.php4” or “.phtml”. PHP’s strength lies in its compatibility
with many types of databases. Also, PHP can talk across networks using IMAP, SNMP,
NNTP, POP3, or HTTP. Today, PHP is shipped standard with a number of Web servers,
including RedHat Linux and as an alternative to Microsoft’s Active Server Pages (ASP)
technology.
MySQL is an open source relational database management system that relies on SQL
for processing the data in the database, which means that it stores data in separate tables
rather than putting all the data in one big area [21]. This adds flexibility, as well as
speed. A database is an organized collection of information that a computer uses to select
and display data. Databases can help organize and enhance the site content. On the
other hand the SQL part of MySQL stands for ”Structured Query Language” which is the
most common language used to access databases. The MySQL database server is most
commonly used for Web applications and for embedded applications and a very popular
database in the world because of unmatched speed, reliability, compactness, stability, and
ease of customization due to its architecture. Their unique separation of the core server
from the storage engine makes it possible to run with very strict control, or with fast disk
access, whichever is more appropriate for the situation. MySQL can run on Windows,
UNIX, Linux and Mac OS operating systems.
In the following section, we briefly introduce our verified decision making model.
2. A Multi-Dimensiona Stochastic-Model To Predict Major Pituitary
Gland Diseases
From the mathematical-modelling point of view, a particular disease, say “A”, may be
associated with a random variable X or equivalently a random set X. For example, if X
is the set of the members which possess the disease “A” for sure, then one can seek the
probability P (X) of a person to be a member of that set [22]-[24].
Disease “A” could be identified as the combination of some physical symptoms desig-
nated by {A1, A2, , AN} where the integer N designates the total number of symptoms
which make up the disease “A”.
Random variables {X1, X2, , XN} may be regarded as the mutually exclusive sets which
are associated with the physical symptoms {A1, A2, , AN} respectively. More explicitly,
Xk could be a set formed with the members who possess the symptom “Ak”. At this
point, we can assess the conditional probability P (X|Xk) for a person having the disease
“A” while possessing the symptom “Ak”.
It is shown that conditional probabilities P (X|Xk) are essential parameters to assess
the probability P (X) for a person who has the disease “A”.
In order to determine conditional probabilities, it may be wise to select a sample set
Xs which has total number of NS members who for sure have the disease “A”. Then, we
construct a training set XT out of the sample set Xs as follows.
Referring to Fig.1, let each independent set {XT ∩Xk; k = 1, 2, .., N} is formed on the
patients of XS who surely possess the disease ”A” with symptom Ak with total number





In this regard, training set XT is constructed on the union of the intersection-sets
(XT ∩Xk) such that
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(a) Event X = (X ∩X1) ∪ ... ∪ (X ∩XN )
(b) Formation of the training set XT with NT =
∑N







Based on the above formation, for each member of XT , probability of having disease
”A” is unity (i.e.P (X) = 1). Furthermore, for each member of Xk probability of P (Xk) =
1 since all the members ofXk possess the symptom Ak. Then, conditional probability
P (X|Xk) may be approximated employing the frequency count fk = nkNT such that











In this context, by using clinical data run over 100 patients, it is verified that one may
employ a Multi-Dimensional Stochastic Linear Model (MD-SLM) to assess the sicknesses
due to mal-functioning of the pituitary-gland. Patients who possess a specific disease such
as Acromegaly, Cushing or Prolactinoma, can be regarded as the members of an event
set X. Here, the random function or equivalently the random set X may be described by
means of mutually exclusive random sets {X1, X2, , XN} as shown in Fig.1.
In Fig.1, event-set X is constructed by means of N- mutually exclusive sets Xk such
that
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X = (X ∩X1) ∪ (X ∩X2) ∪ ... ∪ (X ∩XN ) (4)
In this case, probability of having the event X is given by
P (X) = P (X ∩X1) + P (X ∩X2) + ... + P (X ∩XN ) =
N∑
k=1
P (X ∩Xk) (5)
It should be noted that, while event Xk occurs, conditional probability of having event
X is given by




P (X ∩Xk) = P (X | Xk)P (Xk) (7)





Let us elaborate on (8) as follows.
When event X occurs; P (X) must be equal to one, which in turn makes all P (Xk) equal
to one. Therefore,
∑N




wk = 1 (9)
The above equation can be expressed as a theorem.
2.1. Theorem on Conditional Probabilities. If an event X is generically made out
of N-mutually exclusive complete-events X1, X2, , XN as shown in Fig.1, then sum of
conditional probabilities wk = P (X|Xk) must be equal to one such that
N∑
k=1
wk = 1 (10)
Definition 1: Utility Score or Probability of Occurence
Let y = P (X). Let xk = P (Xk). Then, we say that y is the utility score of the random
event X which describes the probability of occurrence for event X.
Definition 2: Utility Score or Probability of Occurence
The random variable y is called the outcome of a stationary Linear Stochastic System LSS





Definition 3: Utility Score or Probability of Occurence
In LSS, xk is called the independent random input variables whereas y is called the random
output variable of LSS as shown in Fig.2.
Definition 4: Utility Score or Probability of Occurence
In LSS, wks are called the system parameters. They are predicted on the occurred event
X using the conditional probabilities wk = P (X|Xk). In fact, if the set X = (X ∩X1) ∪

















Figure 2. Stationary Linear Stochastic System LSS
(X ∩ X2) ∪ ∪ (X ∩ XN ) is complete, the system parameters wk uniquely determine the
probability of occurrence for the random event X.
Definition 5: Utility Score or Probability of Occurence
By (11), the outcome y = P (X) is the weighted sum of the random inputs xks. In this
regard, the system parameters wks of LSS are also called weight coefficients which operate





Based on above derivations and definitions we can now propose a main statement to
model hormone diseases.
2.2. Main Statement: Stationary Linear Stochastic System (LSS) Model for a
Hormone Disease.
Disease “A” may be described by means of a stationary linear stochastic system LSS
as shown in Fig.2. The system parameters are the weight coefficients wks which works on
the random inputs wks over a linear operator as specified by (11) and they are predicted
employing a training set XT as introduced by (3).
The above systematic approach can be combined under two major design algorithms.
In the first one, we estimate and store the complete set of LSS parameters wks for the
hormone disease under consideration. The second algorithm is devoted to run a self-test.
In the following section brief outline of the algorithms are presented.
3. S/W Design Algorithms For MDSS
The proposed MDSS tool consists of two major blocks. The first one is the training
block to construct a stationary LSS Model for diagnosis purpose. The second one is the
self-test block. These bocks are developed module by module in a sequential manner as
described in the following algorithms.
3.1. S/W Design Algorithm for Block 1: Determination of the Complete Set
of Attributes and Estimation of the Weight Coefficients to Describe the LSS
for Hormone Diseases.
Module 1: Develop a module to collect the clinical data from the patients for sure they
have the disease ”A” under consideration.
Module 2: Develop a module to classify the collected clinical data to extract complete
set of attributes {Ak; k = 1, 2, , N}.
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Module 3: Develop a module to construct a sample set XS using the collected clinical
data.
Module 4: Develop a module to decompose the sample set XS into its attribute sets
{(XT ∩Xk); k = 1, 2, , N}
Module 5: Develop a module to generate the training set XT with
∑N
k nk members as
shown in Fig.1b where XT =
⋃N
k=1(XT ∩Xk)
Module 6: Develop a module to estimate the LSS parameters as wk = nk/NT and store
them for future use in self-tests.
Module 7: Develop a module to combine all the above modules in a sequential manner
under the training Block (S/W Block 1) as shown in Fig. 3(a-b)
3.2. S/W Design Algorithm for Block 2: Development of the Self-Test Mod-
ules.
Module 1: Develop a module which enables user to enter attribute scores P (Xk). It
should be noted P (Xk) s are either 1 or 0 depending on the existence of the attribute that
belongs to the patient.
Module 2: Develop a module which called the LSS parameters wk from the relevant
data-base developed for the disease under consideration
Module 3: Develop a module to compute the outcome of the LSS such that the outcome
y is given by y = P (X) =
∑N
k=1wkP (Xk)
Module 4: Develop a module to check If y = P (X) ≥ 50%. If yes, branch to a data-base
where the detail information about the sickness and expert doctors is provided.
Module 5: Develop a module to check if y = P (X) < 50%. If P (X) < 0.5 then branch
to a data base prepared for the persons who does not have the hormone disease under
consideration. In this case, the directed data-base should include regular medical advises
such as no need to get worry about your health etc.
Module 6: Develop a module to combine all the above modules in a sequential manner
under the self-test block (S/W Block 2) as shown in Fig. 3(a-b)
In the following section, we run a case study to construct a linear stochastic model to
assess the probability P(X) for a person who may be acromegaly.
4. Case Study 1: LSS Model For Acromegaly
Pituitary adenomas are common benign tumors of the pituitary gland. About half of
adenomas secrete too much of one of the pituitary hormones, which are called by functional
pituitary adenomas. Therefore due to hormonal imbalances that affect bodily functions it
can be detected at any age and most of them arise from the anterior lobe of the pituitary
gland. These adenomas have specific signs and symptoms that are primarily related to
the hypersecretion of pituitary hormones, diseases namely, acromegaly (growth hormone
secreting adenoma), Prolactinoma (prolactine secreting adenoma) and Cushing Disease
(Adrenocorticotropic hormone secreting adenoma) [25]-[29].
Acromegaly is caused by increase of growth hormone secretion, with a prevalence of
58130 cases/million people. The most common sign is the enlargement of hands and foot
(change in ring or shoe size), coarsening of facial features, spreading teeth, tongue enlarge-
ment, Carpal tunnel syndrome, excessive perspiration (sweating), oily skin, sleep apnoea,
small outgrowths of skin tissue (skin tags), fatigue and muscle weakness, a deepened
and husky voice, snoring, joint and bone aches, impotence and menstrual irregularities.
Acromegaly can be associated with hypertension, diabetes mellitus and cardiovascular
disease [30]-[38].
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(a) Selection of the sample set XS with NS number of patients who
for sure have the hormone disease ”A” with N distinct attributes.
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(b) Flow chart of self-test module.
Figure 3
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(a) Quality of life in Pituitary Adenomas (b) Different personality traits result in
different coping strategies.
Figure 4
(a) Endocrine system of the human body (b) MR of a human brain with emphasis of Pi-
tuitary Gland
Figure 5
The pituitary gland (sometimes called the master gland) plays a critical role in regu-
lating growth, development, metabolism, and reproduction of a human body. It produces
variety of key hormones like growth hormone, which regulates growth; ACTH (corti-
cotrophin), which stimulates the adrenal glands to produce cortisol; TSH (thyroid stimu-
lation hormone), which stimulates the thyroid gland to produce thyroid hormone; Luteiniz-
ing hormone and follicle-stimulating hormone, which regulate ovulation and estrogen and
progesterone production in women as well as sperm formation and testosterone production
in men. Prolactin hormone stimulates the mammary glands to produce milk production.
When the pituitary gland produces excess growth hormone, this result in excessive growth
called Acromegaly [39].
In Fig.5a, endocrine system of the human body is shown. In Fig. 5b, an actual brain
MR with emphasis of pituitary gland is presented.
Some selected symptoms of acromegaly may be listed as follows.
• swelling of the hands and feet (A1 → X1)
• facial features become coarse as bones grow (A1 → X1)
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(a) X1 → swelling Hands and
feet
(b) X2 → Coarse
Facial Features
(c) X3 → Enlarged lip and
tongue
Figure 6. Problem steps for edge cell users
• enlarged lips, nose, and tongue (A1 → X1)
In view of our proposed linear stochastic system model introduced in Fig.2, the above
symptoms may be regarded as mutually exclusive events or equivalently attributes which
are seen in acromegaly patients. For example, the symptom swelling of hands and feet may
be associated with a random event set X1 constructed by the members of that particular
attribute (i.e.A1). The symptom course facial features as bones grow may be referred with
the random event set X2 formed by the members of attributeA2. Similarly, enlarged lips,
nose and tongue is connected with a random event set X3 constructed with the members
of attribute A3. Some pictures from these events are shown in Fig.6.
Our extensive clinical research reveals that Acromegaly disease may be identified roughly
by means of 19 distinct attributes as listed in Table I. LSS parameters for Acromegaly
can be predicted from a training set XT which is constructed employing a sample set XS
consist of NS = 100 Acromegaly patients for sure having distinct attributes. For example,
out of 100 Acromegaly patients, all of them (i.e. 100 of them) show swelling hands and
feet. In other words, the set (XTX1) is built on n1 = 100 acromegaly patients having
attribute A1. On the other hand, in the sample set XS , 88 patients has Coarse facial
features as bones grow attribute. That is to say, the set (XT | X2) includes n2 = 88
patients. Similarly, the set (XT | X3) which refers to attribute enlarged lips, nose and
tongue includes n3 = 96 patients. The complete list of attributes and their corresponding
populations (nk) of the sets (XT | Xk) are listed in Table I.
Close examination of Table I reveals that the training set XT includes total of NT = 1175
members.
Based on the parameters {wk; k = 1, 2, , 19} given in Table I, a self-test for Acromegaly





In (12), one should ask if the attribute Ak prevails or not. If the answer is yes, then
P (Xk) must be selected as 1. Otherwise, P (Xk) is zero.
Referring to Table II, let us run an example to show the usage of (12).
In Table II, attribute A1 is absent. That means the person running the self-test does not
have excess hair growth. Therefore, we set P (X1) = 0. Similarly, the person neither has
swelling hands, nose and feet nor obesity. Therefore, corresponding probabilities P (X6)
and P (X15) are set to zero. Thus, (11) yields P (X) = 0.83. Hence, we say that, the
person who used the self-test has % 83 chance to be Acromegaly. Therefore, he/she must
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Table 1. Complete Set of Attributes for Acromegaly and its Predicted
LSS Parameters WK
Event Descriptions for the Total number of Weight Coefficients
Sets attributes Ak → Xk members (nk) in wk = P (X | Xk) = nk/NT
the sampled set Xs
with attribute Ak
X ∩X1 Swelling of hands 100 w1 = 0, 085106383
nose and feet
X ∩X2 Coarse Facial features by bones 88 w2 = 0, 074893617
nose and feet
X ∩X3 Enlarged lip, nose, and tongue 96 w3 = 0, 081702128
nose and feet
X ∩X4 Excess hair growth 59 w4 = 0, 050212766
nose and feet
X ∩X5 Headaches 84 w5 = 0, 071489362
nose and feet
X ∩X6 Osteolysis 64 w6 = 0, 054468085
nose and feet
X ∩X7 Joint pain 64 w7 = 0, 054468085
nose and feet
X ∩X8 Impotence in men 36 w8 = 0, 030638298
nose and feet
X ∩X9 Reduced sex drive in men 35 w9 = 0, 029787234
nose and feet
X ∩X10 Loss of vision 30 w10 = 0, 025531915
nose and feet
X ∩X11 Irregular menstrual cycles in women 71 w11 = 0, 060425532
nose and feet
X ∩X12 Stopped menstrual cycles in women 49 w12 = 0, 041702128
nose and feet
X ∩X13 Breast milk production in women 48 w13 = 0, 040851064
nose and feet
X ∩X14 Muscle weakness 18 w14 = 0, 015319149
nose and feet
X ∩X15 Voice deepening 73 w15 = 0, 06212766
nose and feet
X ∩X16 Obesity 46 w16 = 0, 039148936
nose and feet
X ∩X17 Excess perspire 79 w17 = 0, 067234043
nose and feet
X ∩X18 High blood pressure 35 w18 = 0, 029787234
nose and feet
X ∩X19 Non-fitting ring 100 w19 = 0, 085106383
nose and feet
NT = Total number of Certain Acromegaly Patients in the training set XT
NT = 1175
wsum = 1
immediately visit an expert endocrinologist and run further Lab tests and take an MR of
the pituitary gland as guided by the expert doctor etc.
In the following section, we introduce the second case study for Cushing Syndrome
5. Case Study 2: LSS Model For Cushing Syndrome
Cushings disease is one form of Cushings syndrome, which the body produces high level
of cortisol (hypercortisolism) caused by pituitary adenoma. In other words, Cushing Syn-
drome is a disease caused by an excess of cortisol production due to pituitary gland or by
excessive use of cortisol or other similar steroid hormones. The symptoms of hypercorti-
solism are including changes in physical characteristics of the body such as obesity, round
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Table 2. Result of the Self-Test for Pre-Acromegaly Diagnosis
Attributes Event Sets Descriptions for the attributes Ak → Xk Weight Coefficients P (Xk) wkP (Xk)
P (X | Xk) = nk/NT
A1 X ∩X1 Excess hair growth w1 = 0, 085106383 0 0
A2 X ∩X2 Headaches w2 = 0, 074893617 1 0,0714894
A3 X ∩X3 Osteolysis w3 = 0, 081702128 1 0,0544681
A4 X ∩X4 Enlarged lip, nose, and tongue w4 = 0, 050212766 1 0,0817021
A5 X ∩X5 Joint pain w5 = 0, 071489362 1 0,0544681
A6 X ∩X6 Swelling of the hands and feet w6 = 0, 054468085 0 0
A7 X ∩X7 Impotence in men w7 = 0, 054468085 1 0,0306383
A8 X ∩X8 Reduced sex drive in men w8 = 0, 030638298 1 0,0297872
A9 X ∩X9 Loss of vision w9 = 0, 029787234 1 0,0255319
A10 X ∩X10 Irregular menstrual cycles in women w10 = 0, 025531915 1 0,0604255
A11 X ∩X11 Stopped menstrual cycles in women w11 = 0, 060425532 1 0,0417021
A12 X ∩X12 Breast milk production in women w12 = 0, 041702128 1 0,0408511
A13 X ∩X13 Muscle weakness w13 = 0, 040851064 1 0,0153191
A14 X ∩X14 Voice deepening w14 = 0, 015319149 1 0,0621277
A15 X ∩X15 Obesity w15 = 0, 06212766 0 0
A16 X ∩X16 Excess perspire w16 = 0, 039148936 1 0,067234
A17 X ∩X17 High blood pressure w17 = 0, 067234043 1 0,0297872
A18 X ∩X18 Facial features become coarse w18 = 0, 029787234 1 0,0748936
A19 X ∩X19 Non-fitting ring w19 = 0, 085106383 1 0,0851064





or moon face, plethora (red cheeks), added fat on back of neck (buffalo hump) and ab-
dominal excessive weight gain, while the arms and legs to become relatively thin, and thin
skin that bruises easily, abdominal striae, Generalized weakness and fatigue; wasting of
muscles, most noticeably in the upper thighs, osteoporosis and vertebral compression frac-
tures, backache, hypertension, excess hair growth on the face, neck, chest, abdomen and
thighs (hirsutism), menstrual disorders, decreased fertility and/or sex drive, high blood
pressure, diabetes mellitus, mood and behaviour disorders [40]-[44]. All the symptoms of
the Cushing Syndrome are shown in Table III.
Some of the basic symptoms of Cushing Syndrome are given as follows.
• upper body obesity (A1 → X1)
• round face (A2 → X2)
• thinning arms and legs (A3 → X3)
• stretch marks on abdomen (A4 → X4)
• high blood pressure (A5 → X5)
• high blood sugar (A6 → X6)
• irritability and anxiety (A7 → X7)
In view of our proposed mathematical model introduced in Fig.2, the above symptoms
may be regarded as mutually exclusive events or equivalently attributes Xks which are
observed on the patients possessing Cushing Syndromes.
Some pictures from these attributes are shown in Fig.7.
Based on our clinical experience, Cushing Syndrome may be identified roughly by means
of 14 distinct attributes as listed in Table IV. LSS-Parameters for the Cushing Syndrome
may be predicted forming a training set XT as in the previous case study. For this
purpose, we use a sample set XS with 100 Cushing Syndrome patients. For example,
out of 100 Cushing Syndrome patients, 82 of them show Chapped skin. In other words,
intersection set (XT ∩ X1) includes n1 = 82 patients with chapped skin. In the same
sample set, 51 patients have Excess hair growth. That is to say, the intersection set
(XT ∩X2) includes n2 = 51 patients. Similarly, the set (XT ∩X3), which refers to attribute
Headaches has n3 = 49 patients. The complete list of attributes and their corresponding
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(a) Cushing Syndrome
with upper body obesity,
round face and thinning
arms and legs
(b) Stretch marks on abdomen
Figure 7
Table 3. Clinical Features of Cushing Syndrome (All Ages)
Symptoms/Sign Frequency, %
Obesity or weight gain (> 115% ideal body weight) 80
Thin Skin (> 115% ideal body weight) 80
Moon facies (> 115% ideal body weight) 75
Hypertension (> 115% ideal body weight) 75
Purple skin stria (> 115% ideal body weight) 65
Hirsutism (> 115% ideal body weight) 65
Abnormal glucose tolerance (> 115% ideal body weight) 55
Impotence (> 115% ideal body weight) 55
Menstrual disorders (usually amenorrhea) (> 115% ideal body weight) 60
Plethora (> 115% ideal body weight) 60
Proximal muscle weakness (> 115% ideal body weight) 50
Truncal obesity (> 115% ideal body weight) 50
Acne (> 115% ideal body weight) 45
Brusing (> 115% ideal body weight) 45
Mental changes (> 115% ideal body weight) 45
Osteoporosis (> 115% ideal body weight) 40
Edema of lower extremities (> 115% ideal body weight) 30
Hyperpigmentation (> 115% ideal body weight) 20
Hypokalemic alkalosis (> 115% ideal body weight) 15
Diabetes mellitus (> 115% ideal body weight) 15
populations (nk) of (XT ∩Xk) s are listed in Table IV. As in Table I, weight coefficients
for LSS is approximated using the frequency calculations over NT = 836 patients such
that w1 = 82(836 = 0.098), w2 = 51/836 = 0.061, w3 = 49(836 = 0.058) etc.
In Table V, a self- test was run for a person who was suspicious to have the Cushing
Syndrome. He selected P (X1) = P (X2) = P (X3) = P (X11) = P (X12) = P (X13) =
P (X14) = 0 and the rest of P (Xk) were set to 1. Thus, it is found that his chance to have
Cushing Syndrome is 39.8%. Our threshold level is 50%. Therefore, he does not need to
bother to visit an endocrinologist for Cushing Syndrome. Finally, in the following section
we present the case study on Prolactinoma.
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Table 4. Complete Attributes Extracted From Cushing Syndrome Pa-
tients and Computations of Their Corresponding Weight Coefficients
Attributes Event Sets for Descriptions for the attributes Total number of members Weight Coefficients
Cushing Syndrome (Ak → Xk) (nk) in the sample set Xs with wk = P (X | Xk) = nk/NT
attribute Ak
A1 X ∩X1 Chapped Skin 82 w1 = 0, 098086124
A2 X ∩X2 Excess hair growth 51 w2 = 0, 061004785
A3 X ∩X3 Headaches 49 w3 = 0, 05861244
A4 X ∩X4 Depression (discomfort, stress, anxiety) 33 w4 = 0, 039473684
A5 X ∩X5 Fragile skin 51 w5 = 0, 061004785
A6 X ∩X6 Increased fat around neck 75 w6 = 0, 089712919
A7 X ∩X7 Impotence in men 10 w7 = 0, 011961722
A8 X ∩X8 Irregular menstrual cycles in women 53 w8 = 0, 063397129
A9 X ∩X9 Muscle weakness 61 w9 = 0, 072966507
A10 X ∩X10 High blood sugar 50 w10 = 0, 059808612
A11 X ∩X11 Obesity 77 w11 = 0, 092105263
A12 X ∩X12 Acnes 82 w12 = 0, 098086124
A13 X ∩X13 High blood pressure 80 w13 = 0, 095693784
A14 X ∩X14 Red round face 82 w14 = 0, 098086124
NT =Total number of Certain Cushing Syndrome Patients in the NT = 836 wsum = 1
training set XT
6. Case Study 3: LSS Model For Prolactinoma
A Prolactinoma is a benign tumor of the pituitary gland. Symptoms of prolactinoma are
caused by too much prolactin in the blood or by pressure on the tumor by the surrounding
tissues. Prolactin stimulates the breast to produce milk during pregnancy and nursing
period after delivery.
Prolactin-secretion adenomas are the most common, and account for approximately
30% of all pituitary tumors. Symptoms of prolactinoma depend on the excessive secretion
of prolactin hormone (hyperprolactinaemia) from the tumor and pressure of the tumor
on adjacent tissues. Therefore hyperprolactinemia induced galactorrhea (milky breast dis-
charge), absent or irregular menstrual periods, low sex drive, vaginal dryness and difficulty
achieving pregnancy. Controversially, macro-adenomas cause visual field defect (pressure
in optic nerves), headaches and cause sexual dysfunction and infertility mainly in men
[46]-[48].
Some of the basic symptoms of prolactinoma is given as follows.
• Infertility (A1 → X1)
• Headaches (A2 → X2)
• Impotence, reduced sex drive and enlargement of breasts in men (A3 → X3)
• Breast milk production; irregular or stopped or non-menstrual cycles in women
(A4 → X4)
Our extensive clinical studies indicate that Prolactinoma can be pre-diagnosed by means
9 distinct attributes as listed in Table VI.
LSS parameters for Prolactinoma are predicted employing a training set XT . The set
XT was constructed on the sample set XS formed among the NS = 100 patients who have
for sure Prolactinoma. For example, in the sample set XS , n1 = 67 number of patients
exhibit attribute Headaches; n2 = 22 number of patients show impotence etc. Thus,
we end up with total of NT = 279 members in the training set XT . Then, parameters
wk = nkNT are estimated. In this regards, w1 = 67279 = 0.24, w2 = 22279 = 0.0788 etc.
Hence, we up with all the LSS parameters as listed in column 5 of Table VI. Using Table
VI, anyone can run a self-test as described in the previous study cases.
184 TWMS J. APP. ENG. MATH. V.5, N.2, 2015
Table 5. Self-Test For Cushing Syndrome
Attributes Event Sets for Explanation for the attributes Weight Coefficients P (Xk) wk = P (Xk)
Cushing Syndrome wk = P (X | Xk) = nk/NT
A1 X ∩X1 Chapped Skin 0,098086124 0 0
A2 X ∩X2 Excess hair growth 0,061004785 0 0
A3 X ∩X3 Headaches 0,05861244 0 0
A4 X ∩X4 Depression (discomfort, stress, anxiety) 0,039473684 1 0,039473684
A5 X ∩X5 Fragile skin 0,061004785 1 0,061004785
A6 X ∩X6 Increased fat around neck 0,089712919 1 0,089712919
A7 X ∩X7 Impotence in men 0,011961722 1 0,011961722
A8 X ∩X8 Irregular menstrual cycles in women 0,063397129 1 0,063397129
A9 X ∩X9 Muscle weakness 0,072966507 1 0,072966507
A10 X ∩X10 High blood sugar 0,059808612 1 0,059808612
A11 X ∩X11 Obesity 0,092105263 0 0
A12 X ∩X12 Acnes 0,098086124 0 0
A13 X ∩X13 High blood pressure 0,09569378 0 0
A14 X ∩X14 Red round face 0,098086124 0 0
Test result run for the person for the pre-diagnosis of Cushing Syndrome wsum = 1 P (X) = 0, 398
Table 6. Complete Attributes Extracted Cushing Syndrome Patients and
Computations of Their Corresponding Weight Coefficients
Attributes Event Sets for Descriptions for the attributes Ak → Xk Total number of Weight Coefficients
Cushing Syndrome members (nk) in the wk = P (X | Xk) = nk/NT
sample set Xs with
attribute Ak
A1 X ∩X1 Headaches 67 w1 = 0, 240143369
A2 X ∩X2 Impotence in men 22 w2 = 0, 078853047
A3 X ∩X3 Reduced sex drive in men 11 w3 = 0, 039426523
A4 X ∩X4 Enlargement of breast in men 6 w4 = 0, 021505376
A5 X ∩X5 Infertility 28 w5 = 0, 100358423
A6 X ∩X6 Irregular menstrual cycles in women 6 w6 = 0, 021505376
A7 X ∩X7 Stopped menstrual cycles in women 44 w7 = 0, 157706093
A8 X ∩X8 No menstrual cycles in women 17 w8 = 0, 0609319
A9 X ∩X9 Breast milk production in women 78 w9 = 0, 279569892
NT =Total number of Certain Prolactinoma Patients in Set X NT = 279 wsum = 1
7. Closing Remarks and Conclusion
In these days, whenever we complaint about our health, we immediately surf on the
internet to search for the symptoms we feel. In the course of search process, it is very easy
to face medical information pollution which confuses us where to go and whom to look
for to receive proper medical help. This fact may create psychological stress and anxiety
which may further aggravate our sickness and rush us to seek for the relevant and the
irrelevant medical care. The end result is loss of “health”, “aggravation of the illness”,
loss of “time” and “money”. On the other hand, if the patient coincides with a complete
medical self-test tool, he/she may end up with early diagnosis and perhaps directed to a
proper medical center. In this regard, Medical Decision Support Systems may be useful
for family practitioners to guide the patients to the correct addresses.
In this work, we have chosen the liberty to develop a reliable medical decision support
tool for early diagnosis of hormone diseases namely, acromegaly, cushing and prolactinoma.
The tool prevents malpractice, saves time, effort and money both for patients and expert
medical doctors.
The proposed tool is based on a Stationary Linear Stochastic System to model hormone
diseases. In the model, hormone diseases are described by means of their complete set
of attributes. Attributes stems from the physical symptoms and they are quantified by
calculating their portion on the overall disease by estimating conditional probabilities.
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Outcome of the system is the probability of having the specific disease by the person who
is running the self-test. It is verified that the model proposed in this research work results
in more than 99% accurate decisions for early diagnosis of the particular disease under
consideration. As the continuation of this work, our intension is to wide spread the pre-
diagnostic decision support tool on mobile platforms in Europe and Associated Countries
by means of an EU Horizon 2020 project.
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